Heidelberg Pharma AG (LON:0QW5)
2.830
+0.060 (2.17%)
At close: Dec 12, 2025
Heidelberg Pharma AG Revenue
Heidelberg Pharma AG had revenue of 47.13K EUR in the quarter ending August 31, 2025, a decrease of -96.05%. This brings the company's revenue in the last twelve months to 3.04M, down -64.15% year-over-year. In the fiscal year ending November 30, 2024, Heidelberg Pharma AG had annual revenue of 6.85M, down -30.53%.
Revenue (ttm)
3.04M EUR
Revenue Growth
-64.15%
P/S Ratio
43.92
Revenue / Employee
28.93K EUR
Employees
105
Market Cap
115.53M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 6.85M | -3.01M | -30.53% |
| Nov 30, 2023 | 9.86M | -8.66M | -46.75% |
| Nov 30, 2022 | 18.51M | 16.48M | 810.30% |
| Nov 30, 2021 | 2.03M | -6.63M | -76.53% |
| Nov 30, 2020 | 8.67M | 1.17M | 15.63% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |